MedPath

Suicide Prevention Programme for Deaddiction Centre

Phase 3
Not yet recruiting
Conditions
Alcohol dependence,
Registration Number
CTRI/2023/03/050896
Lead Sponsor
University Grant Commission
Brief Summary

***Background of the study***

Suicide is a significant public health issue worldwide, particularly in India, where its multi-factorial etiology affects both the health and social sectors. Since, Substance use is one of the prominent risk factors for suicide, more efforts to address suicidality in the population needs to be initiated. Also, best of our knowledge, the current treatment is not addressing the preventive measures for suicide. It is crucial to develop interventions to address suicide prevention in this view. The current study aims to develop and pilot testing a suicide prevention program for persons with substance use disorder.

***Method***

The study will be adopted a mixed-method research design. The first two phases would adopt a qualitative research design to review the literature and need assessment to develop the suicide prevention program. The third phase would be using a Quasi-experimental mixed method research design, a waitlist comparison group with pretest-posttest, and a three month follow up to pilot testing of the developed programme. To recruit the participants in the quantitative and qualitative phases will adopt the consecutive sampling and the purposive sampling method, respectively. The persons taking treatment from the Centre for Addiction Medicine (CAM) NIMHANS are considered the study population. The study will be carried out in the IP service of CAM.

***Implication***

The study focuses on developing suicide prevention initiatives in addiction settings, considering that persons with substance use disorder are at high risk of suicide attempts and suicide. The current study addresses the gap between suicide prevention in addiction treatment. Primarily, the suicide prevention programme might be helping the participants in improving their help seeking for reducing suicidal behaviours. It also enhance knowledge and reduce the stigma toward suicide.

***Conclusion***

Contextually appropriate and culturally sensitive suicide prevention programmes can be protective factors preventing suicide attempts and suicide in post discharging scenarios. Inculcating the programme to the regular deaddiction treatment will be an effective strategy for suicide prevention. Additionally, the study outcome can be an integral part of the national suicide prevention strategy.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Participants who are taking in-patient treatment from the Centre for Addiction Medicine, NIMHANS.
  • Participants were diagnosed with substance use disorder.
  • Aged between 18-59 years.
  • Participants who can speak either Kannada, English, Malayalam or Tamil.
Exclusion Criteria
  • Participants who have persisting psychotic symptoms, complex withdrawal, and cognitive impairments.
  • Participants who have chronic medical conditions.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary Outcome: Improve help seeking to reduce suicidal behaviours.at baseline, 4 weeks, and 8 weeks
Secondary Outcome Measures
NameTimeMethod
Enhancement in Knowledge of suicidal behavioursReduction of Stigma towards Suicide

Trial Locations

Locations (1)

National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru

🇮🇳

Bangalore, KARNATAKA, India

National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru
🇮🇳Bangalore, KARNATAKA, India
Muhammed Noorudheen
Principal investigator
9895877669
munoorinn@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.